日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

m6A methyltransferase METTL14‑mediated RP1‑228H13.5 promotes the occurrence of liver cancer by targeting hsa‑miR‑205/ZIK1

m6A甲基转移酶METTL14介导的RP1-228H13.5通过靶向hsa-miR-205/ZIK1促进肝癌的发生

Jia Xu, Chang Liu, Kai Qu, Jingyao Zhang, Sinan Liu, Fandi Meng, Yong Wan

The mechanism of polyphyllin in the treatment of gastric cancer was verified based on network pharmacology and experimental validation

基于网络药理学和实验验证多叶素治疗胃癌的作用机制

Doudou Lu, Ling Yuan, Xiaoyan Ma, Fandi Meng, Duojie Xu, Shumin Jia, Zhaozhao Wang, Yahong Li, Zhe Zhang, Yi Nan

Network pharmacology and in vitro experiments to investigate the anti-gastric cancer effects of paeoniflorin through the RAS/MAPK signaling pathway

网络药理学及体外实验探讨芍药苷通过RAS/MAPK信号通路的抗胃癌作用

Yating Yang, Ling Yuan, Yuhua Du, Mengyi Ye, Doudou Lu, Shicong Huang, Jianjun Zhao, Joanna Japhet Tibenda, Fandi Meng, Yi Nan

Pan-cancer analysis of NUDT21 and its effect on the proliferation of human head and neck squamous cell carcinoma

NUDT21的泛癌分析及其对人头颈部鳞状细胞癌增殖的影响

Wenjing Liu, Yingna Pang, Xiaolu Yu, Doudou Lu, Yating Yang, Fandi Meng, Chengbi Xu, Ling Yuan, Yi Nan

Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1G93A ALS mouse model

hSOD1G93A ALS 小鼠模型中细胞焦亡和典型炎症小体通路的时空演变

Haoyun Zhang #, Hao Li #, Bingkun Huang, Shaoye Wang, Ying Gao, Fandi Meng, Yanchun Chen, Fenghua Zhou, Yingjun Guan, Xin Wang

CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis

CircIL4R通过调节miR-541-3p/GPX4轴促进肝细胞癌的肿瘤发生并抑制铁死亡

Qinhong Xu, Lijing Zhou, Ganghua Yang, Fandi Meng, Yong Wan, Lin Wang, Lei Zhang

Functional analysis of miR-767-5p during the progression of hepatocellular carcinoma and the clinical relevance of its dysregulation

miR-767-5p 在肝细胞癌进展过程中的功能分析及其失调的临床意义

Lei Zhang, Zhimin Geng, Yong Wan, Fandi Meng, Xiankui Meng, Lin Wang

Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations

细胞外 miRNA-21 作为胶质瘤的新生物标志物:来自荟萃分析、临床验证和实验研究的证据

Kai Qu, Ting Lin, Qing Pang, Tian Liu, Zhixin Wang, Minghui Tai, Fandi Meng, Jingyao Zhang, Yong Wan, Ping Mao, Xiaoqun Dong, Chang Liu, Wenquan Niu, Shunbin Dong